MedCap AB (CHIX:MCAPS) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MCAPS MedCap AB CHIX:MCAPS
93 GF Score
Price kr555.00
GF Value kr596.05
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:MCAPS vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, MedCap AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedCap AB Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Short Interest distribution charts can be found below:

* The bar in red indicates where MedCap AB's Short Interest falls into.


CHIX:MCAPS
93GF Score
MedCap AB CHIX:MCAPS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MedCap AB (CHIX:MCAPS) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr555.00 is trading 6.9% below its estimated GF Value™ of kr596.05. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for CHIX:MCAPS:

  • Short Interest:
  • GF Value™: kr596.05 vs. price of kr555.00 (6.9% below fair value)
  • GF Score™: 93/100

No single metric tells the full story. See the CHIX:MCAPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MedCap AB Business Description

Other Exchanges MCAP:Sweden61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
93GF Score

Get the complete analysis for CHIX:MCAPS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr555.00
Price
kr596.05
GF Value